ArticleBiomedicines2022

Does a High-Risk (>1/50) Result for First-Trimester Combined Screening Always Entail Invasive Testing? Which Patients from This Group Might Benefit from cfDNA Testing?

Rocío García-Jiménez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.